Evidence map›Paper›PMID 25855068›Full record

ArticleJournal of human genetics2015

Japan PGx Data Science Consortium Database: SNPs and HLA genotype data from 2994 Japanese healthy individuals for pharmacogenomics studies.

Shigeo Kamitsuji, Takashi Matsuda, Koichi Nishimura, Seiko Endo, Chisa Wada, Kenji Watanabe, Koichi Hasegawa, Haretsugu Hishigaki, Masatoshi Masuda, Yusuke Kuwahara and 18 more

Open access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in Journal of human genetics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 25 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Associations ofGenes · 2023
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors at 8 institutions in 1 country.

Shigeo KamitsujiStaGen, Tokyo, Japan.
Takashi MatsudaAstellas Pharma, Tokyo, Japan.
Koichi NishimuraAstellas Pharma, Tokyo, Japan.
Seiko EndoDaiichi Sankyo, Tokyo, Japan.
Chisa WadaDaiichi Sankyo, Tokyo, Japan.
Kenji WatanabeDaiichi Sankyo, Tokyo, Japan.
Koichi HasegawaOtsuka Pharmaceutical, Tokyo, Japan.
Haretsugu HishigakiOtsuka Pharmaceutical, Tokyo, Japan.
Masatoshi MasudaOtsuka Pharmaceutical, Tokyo, Japan.
Yusuke KuwaharaTaisho Pharmaceutical, Tokyo, Japan.
Katsuki TsuritaniTaisho Pharmaceutical, Tokyo, Japan.
Kenkichi SugiuraTakeda Pharmaceutical Company Limited, Osaka, Japan.
Tomoko KubotaMitsubishi Tanabe Pharma Corporation, Osaka, Japan.
Shinji MiyoshiMitsubishi Tanabe Pharma Corporation, Osaka, Japan.
Kinya OkadaMitsubishi Tanabe Pharma Corporation, Osaka, Japan.
Kazuyuki NakazonoStaGen, Tokyo, Japan.
Yuki SugayaStaGen, Tokyo, Japan.
Woosung YangStaGen, Tokyo, Japan.
Taiji SawamotoAstellas Pharma, Tokyo, Japan.
Wataru UchidaAstellas Pharma, Tokyo, Japan.
Akira ShinagawaDaiichi Sankyo, Tokyo, Japan.
Tsutomu FujiwaraOtsuka Pharmaceutical, Tokyo, Japan.
Hisaharu YamadaTaisho Pharmaceutical, Tokyo, Japan.
Koji SuematsuTaisho Pharmaceutical, Tokyo, Japan.
Naohisa TsutsuiMitsubishi Tanabe Pharma Corporation, Osaka, Japan.
Naoyuki KamataniStaGen, Tokyo, Japan.
Shyh-Yuh LiouTakeda Pharmaceutical Company Limited, Osaka, Japan.
Japan PGx Data Science Consortium (JPDSC)
StaGen (Japan) · JPAstellas Pharma (Japan) · JPDaiichi-Sankyo (Japan) · JPOtsuka (Japan) · JPTaisho Pharmaceutical (Japan) · JPMitsubishi Chemical (Japan) · JPMitsubishi Tanabe Pharma CorporationTakeda (Japan) · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Japan Pharmacogenomics Data Science Consortium (JPDSC) has assembled a database for conducting pharmacogenomics (PGx) studies in Japanese subjects. The database contains the genotypes of 2.5 million single-nucleotide polymorphisms (SNPs) and 5 human leukocyte antigen loci from 2994 Japanese healthy volunteers, as well as 121 kinds of clinical information, including self-reports, physiological data, hematological data and biochemical data. In this article, the reliability of our data was evaluated by principal component analysis (PCA) and association analysis for hematological and biochemical traits by using genome-wide SNP data. PCA of the SNPs showed that all the samples were collected from the Japanese population and that the samples were separated into two major clusters by birthplace, Okinawa and other than Okinawa, as had been previously reported. Among 87 SNPs that have been reported to be associated with 18 hematological and biochemical traits in genome-wide association studies (GWAS), the associations of 56 SNPs were replicated using our data base. Statistical power simulations showed that the sample size of the JPDSC control database is large enough to detect genetic markers having a relatively strong association even when the case sample size is small. The JPDSC database will be useful as control data for conducting PGx studies to explore genetic markers to improve the safety and efficacy of drugs either during clinical development or in post-marketing.

Indexed as

Databases, GeneticFemaleGene FrequencyGenetic Association StudiesGenotypeHealthy VolunteersHLA AntigensHumansJapanMalePharmacogeneticsPolymorphism, Single NucleotideHLA Antigens

Identifiers

PMID25855068
OpenAlexW2024023753

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.